Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice Article Swipe
Raffaella Rossin
,
Ron M. Versteegen
,
Jeremy Wu
,
Alisher Khasanov
,
Hans J. C. T. Wessels
,
Erik J. Steenbergen
,
Wolter ten Hoeve
,
Henk M. Janssen
,
Arthur H. A. M. van Onzen
,
Peter J. Hudson
,
Marc S. Robillard
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1038/s41467-019-08376-x
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1038/s41467-019-08376-x
Related Topics
Concepts
Drug
Conjugate
Pharmacology
Antibody
Antibody-drug conjugate
Chemistry
Medicine
Immunology
Monoclonal antibody
Mathematics
Mathematical analysis
Metadata
- Type
- erratum
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41467-019-08376-x
- https://www.nature.com/articles/s41467-019-08376-x.pdf
- OA Status
- gold
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2923633313
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2923633313Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41467-019-08376-xDigital Object Identifier
- Title
-
Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in miceWork title
- Type
-
erratumOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-01-16Full publication date if available
- Authors
-
Raffaella Rossin, Ron M. Versteegen, Jeremy Wu, Alisher Khasanov, Hans J. C. T. Wessels, Erik J. Steenbergen, Wolter ten Hoeve, Henk M. Janssen, Arthur H. A. M. van Onzen, Peter J. Hudson, Marc S. RobillardList of authors in order
- Landing page
-
https://doi.org/10.1038/s41467-019-08376-xPublisher landing page
- PDF URL
-
https://www.nature.com/articles/s41467-019-08376-x.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41467-019-08376-x.pdfDirect OA link when available
- Concepts
-
Drug, Conjugate, Pharmacology, Antibody, Antibody-drug conjugate, Chemistry, Medicine, Immunology, Monoclonal antibody, Mathematics, Mathematical analysisTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2020: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2923633313 |
|---|---|
| doi | https://doi.org/10.1038/s41467-019-08376-x |
| ids.doi | https://doi.org/10.1038/s41467-019-08376-x |
| ids.mag | 2923633313 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30651544 |
| ids.openalex | https://openalex.org/W2923633313 |
| fwci | 0.17762525 |
| type | erratum |
| title | Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice |
| biblio.issue | 1 |
| biblio.volume | 10 |
| biblio.last_page | 363 |
| biblio.first_page | 363 |
| topics[0].id | https://openalex.org/T10756 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.5849000215530396 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Estrogen and related hormone effects |
| topics[1].id | https://openalex.org/T13160 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.5525000095367432 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1605 |
| topics[1].subfield.display_name | Organic Chemistry |
| topics[1].display_name | Synthesis and Biological Evaluation |
| topics[2].id | https://openalex.org/T12561 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.5034000277519226 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | bioluminescence and chemiluminescence research |
| is_xpac | False |
| apc_list.value | 3920 |
| apc_list.currency | GBP |
| apc_list.value_usd | 4808 |
| apc_paid.value | 3920 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 4808 |
| concepts[0].id | https://openalex.org/C2780035454 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8254813551902771 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[0].display_name | Drug |
| concepts[1].id | https://openalex.org/C197336794 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8012124300003052 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5161150 |
| concepts[1].display_name | Conjugate |
| concepts[2].id | https://openalex.org/C98274493 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5945563316345215 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[2].display_name | Pharmacology |
| concepts[3].id | https://openalex.org/C159654299 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5269195437431335 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[3].display_name | Antibody |
| concepts[4].id | https://openalex.org/C2777325958 |
| concepts[4].level | 4 |
| concepts[4].score | 0.5036880373954773 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1069596 |
| concepts[4].display_name | Antibody-drug conjugate |
| concepts[5].id | https://openalex.org/C185592680 |
| concepts[5].level | 0 |
| concepts[5].score | 0.4655168056488037 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[5].display_name | Chemistry |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.3545214533805847 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C203014093 |
| concepts[7].level | 1 |
| concepts[7].score | 0.22878170013427734 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[7].display_name | Immunology |
| concepts[8].id | https://openalex.org/C542903549 |
| concepts[8].level | 3 |
| concepts[8].score | 0.1948651373386383 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q422248 |
| concepts[8].display_name | Monoclonal antibody |
| concepts[9].id | https://openalex.org/C33923547 |
| concepts[9].level | 0 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[9].display_name | Mathematics |
| concepts[10].id | https://openalex.org/C134306372 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7754 |
| concepts[10].display_name | Mathematical analysis |
| keywords[0].id | https://openalex.org/keywords/drug |
| keywords[0].score | 0.8254813551902771 |
| keywords[0].display_name | Drug |
| keywords[1].id | https://openalex.org/keywords/conjugate |
| keywords[1].score | 0.8012124300003052 |
| keywords[1].display_name | Conjugate |
| keywords[2].id | https://openalex.org/keywords/pharmacology |
| keywords[2].score | 0.5945563316345215 |
| keywords[2].display_name | Pharmacology |
| keywords[3].id | https://openalex.org/keywords/antibody |
| keywords[3].score | 0.5269195437431335 |
| keywords[3].display_name | Antibody |
| keywords[4].id | https://openalex.org/keywords/antibody-drug-conjugate |
| keywords[4].score | 0.5036880373954773 |
| keywords[4].display_name | Antibody-drug conjugate |
| keywords[5].id | https://openalex.org/keywords/chemistry |
| keywords[5].score | 0.4655168056488037 |
| keywords[5].display_name | Chemistry |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.3545214533805847 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/immunology |
| keywords[7].score | 0.22878170013427734 |
| keywords[7].display_name | Immunology |
| keywords[8].id | https://openalex.org/keywords/monoclonal-antibody |
| keywords[8].score | 0.1948651373386383 |
| keywords[8].display_name | Monoclonal antibody |
| language | en |
| locations[0].id | doi:10.1038/s41467-019-08376-x |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S64187185 |
| locations[0].source.issn | 2041-1723 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2041-1723 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Nature Communications |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s41467-019-08376-x.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nature Communications |
| locations[0].landing_page_url | https://doi.org/10.1038/s41467-019-08376-x |
| locations[1].id | pmid:30651544 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Nature communications |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30651544 |
| locations[2].id | pmh:oai:doaj.org/article:6c6c398d9bb1484b823a40a0b2f2a49e |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Nature Communications, Vol 10, Iss 1, Pp 1-1 (2019) |
| locations[2].landing_page_url | https://doaj.org/article/6c6c398d9bb1484b823a40a0b2f2a49e |
| locations[3].id | pmh:oai:doaj.org/article:fea92d6bbdb8481183adf2d4a9442582 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Nature Communications, Vol 10, Iss 1, Pp 1-1 (2019) |
| locations[3].landing_page_url | https://doaj.org/article/fea92d6bbdb8481183adf2d4a9442582 |
| locations[4].id | pmh:oai:pure.tue.nl:openaire/a23c61fe-a9f2-4ee4-8629-04f994c37d6c |
| locations[4].is_oa | True |
| locations[4].source | |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Rossin, R, Versteegen, R M, Wu, J, Khasanov, A, Wessels, H J, Steenbergen, E J, ten Hoeve, W, Janssen, H M, van Onzen, A H A M, Hudson, P J & Robillard, M S 2019, 'Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice : (Nature Communications, (2018), 9, 1, (1484), 10.1038/s41467-018-03880-y)', Nature Communications, vol. 10, no. 1, 363. https://doi.org/10.1038/s41467-019-08376-x |
| locations[4].landing_page_url | https://research.tue.nl/en/publications/a23c61fe-a9f2-4ee4-8629-04f994c37d6c |
| locations[5].id | pmh:oai:pubmedcentral.nih.gov:6335410 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S2764455111 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | PubMed Central |
| locations[5].source.host_organization | https://openalex.org/I1299303238 |
| locations[5].source.host_organization_name | National Institutes of Health |
| locations[5].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[5].license | other-oa |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Text |
| locations[5].license_id | https://openalex.org/licenses/other-oa |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | Nat Commun |
| locations[5].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6335410 |
| locations[6].id | pmh:oai:europepmc.org:5311544 |
| locations[6].is_oa | True |
| locations[6].source.id | https://openalex.org/S4306400806 |
| locations[6].source.issn | |
| locations[6].source.type | repository |
| locations[6].source.is_oa | False |
| locations[6].source.issn_l | |
| locations[6].source.is_core | False |
| locations[6].source.is_in_doaj | False |
| locations[6].source.display_name | Europe PMC (PubMed Central) |
| locations[6].source.host_organization | https://openalex.org/I1303153112 |
| locations[6].source.host_organization_name | European Bioinformatics Institute |
| locations[6].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[6].license | other-oa |
| locations[6].pdf_url | |
| locations[6].version | submittedVersion |
| locations[6].raw_type | Text |
| locations[6].license_id | https://openalex.org/licenses/other-oa |
| locations[6].is_accepted | False |
| locations[6].is_published | False |
| locations[6].raw_source_name | |
| locations[6].landing_page_url | http://europepmc.org/pmc/articles/PMC6335410 |
| locations[7].id | pmh:tue:oai:pure.tue.nl:publications/a23c61fe-a9f2-4ee4-8629-04f994c37d6c |
| locations[7].is_oa | True |
| locations[7].source.id | https://openalex.org/S4306401843 |
| locations[7].source.issn | |
| locations[7].source.type | repository |
| locations[7].source.is_oa | False |
| locations[7].source.issn_l | |
| locations[7].source.is_core | False |
| locations[7].source.is_in_doaj | False |
| locations[7].source.display_name | Data Archiving and Networked Services (DANS) |
| locations[7].source.host_organization | https://openalex.org/I1322597698 |
| locations[7].source.host_organization_name | Royal Netherlands Academy of Arts and Sciences |
| locations[7].source.host_organization_lineage | https://openalex.org/I1322597698 |
| locations[7].license | other-oa |
| locations[7].pdf_url | |
| locations[7].version | submittedVersion |
| locations[7].raw_type | info:eu-repo/semantics/article |
| locations[7].license_id | https://openalex.org/licenses/other-oa |
| locations[7].is_accepted | False |
| locations[7].is_published | False |
| locations[7].raw_source_name | Nature Communications, 10(1):363. Nature Publishing Group |
| locations[7].landing_page_url | https://research.tue.nl/nl/publications/a23c61fe-a9f2-4ee4-8629-04f994c37d6c |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5104475617 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Raffaella Rossin |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210128216 |
| authorships[0].affiliations[0].raw_affiliation_string | Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands |
| authorships[0].institutions[0].id | https://openalex.org/I4210128216 |
| authorships[0].institutions[0].ror | https://ror.org/0364yac91 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210128216 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | Tagworks Pharmaceuticals (Netherlands) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Raffaella Rossin |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands |
| authorships[1].author.id | https://openalex.org/A5029630200 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0832-5120 |
| authorships[1].author.display_name | Ron M. Versteegen |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210127742 |
| authorships[1].affiliations[0].raw_affiliation_string | SyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands |
| authorships[1].institutions[0].id | https://openalex.org/I4210127742 |
| authorships[1].institutions[0].ror | https://ror.org/03em0vf53 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210127742 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | SyMO-Chem (Netherlands) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ron M. Versteegen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | SyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands |
| authorships[2].author.id | https://openalex.org/A5084835848 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5304-3552 |
| authorships[2].author.display_name | Jeremy Wu |
| authorships[2].affiliations[0].raw_affiliation_string | Avipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jeremy Wu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Avipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia |
| authorships[3].author.id | https://openalex.org/A5061892497 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Alisher Khasanov |
| authorships[3].affiliations[0].raw_affiliation_string | Levena Biopharma, 4955 Directors Place, Suite 300, San Diego, CA, 92121, USA |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Alisher Khasanov |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Levena Biopharma, 4955 Directors Place, Suite 300, San Diego, CA, 92121, USA |
| authorships[4].author.id | https://openalex.org/A5061175424 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5957-3127 |
| authorships[4].author.display_name | Hans J. C. T. Wessels |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949 |
| authorships[4].affiliations[0].raw_affiliation_string | Radboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands |
| authorships[4].institutions[0].id | https://openalex.org/I2802934949 |
| authorships[4].institutions[0].ror | https://ror.org/05wg1m734 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2802934949 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | Radboud University Medical Center |
| authorships[4].institutions[1].id | https://openalex.org/I145872427 |
| authorships[4].institutions[1].ror | https://ror.org/016xsfp80 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I145872427 |
| authorships[4].institutions[1].country_code | NL |
| authorships[4].institutions[1].display_name | Radboud University Nijmegen |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Hans J. Wessels |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Radboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands |
| authorships[5].author.id | https://openalex.org/A5078696402 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Erik J. Steenbergen |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Pathology, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands |
| authorships[5].institutions[0].id | https://openalex.org/I2802934949 |
| authorships[5].institutions[0].ror | https://ror.org/05wg1m734 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2802934949 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | Radboud University Medical Center |
| authorships[5].institutions[1].id | https://openalex.org/I145872427 |
| authorships[5].institutions[1].ror | https://ror.org/016xsfp80 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I145872427 |
| authorships[5].institutions[1].country_code | NL |
| authorships[5].institutions[1].display_name | Radboud University Nijmegen |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Erik J. Steenbergen |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Pathology, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands |
| authorships[6].author.id | https://openalex.org/A5009095014 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Wolter ten Hoeve |
| authorships[6].countries | NL |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210093675 |
| authorships[6].affiliations[0].raw_affiliation_string | Syncom B.V., Kadijk 3, 9747 AT, Groningen, The Netherlands |
| authorships[6].institutions[0].id | https://openalex.org/I4210093675 |
| authorships[6].institutions[0].ror | https://ror.org/00jmt8d06 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210090588, https://openalex.org/I4210093675, https://openalex.org/I4210140876 |
| authorships[6].institutions[0].country_code | NL |
| authorships[6].institutions[0].display_name | Radiocommunications Agency |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Wolter ten Hoeve |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Syncom B.V., Kadijk 3, 9747 AT, Groningen, The Netherlands |
| authorships[7].author.id | https://openalex.org/A5080214970 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2588-846X |
| authorships[7].author.display_name | Henk M. Janssen |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210127742 |
| authorships[7].affiliations[0].raw_affiliation_string | SyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands |
| authorships[7].institutions[0].id | https://openalex.org/I4210127742 |
| authorships[7].institutions[0].ror | https://ror.org/03em0vf53 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210127742 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | SyMO-Chem (Netherlands) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Henk M. Janssen |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | SyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands |
| authorships[8].author.id | https://openalex.org/A5084891724 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Arthur H. A. M. van Onzen |
| authorships[8].countries | NL |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210128216 |
| authorships[8].affiliations[0].raw_affiliation_string | Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands |
| authorships[8].institutions[0].id | https://openalex.org/I4210128216 |
| authorships[8].institutions[0].ror | https://ror.org/0364yac91 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210128216 |
| authorships[8].institutions[0].country_code | NL |
| authorships[8].institutions[0].display_name | Tagworks Pharmaceuticals (Netherlands) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Arthur H. A. M. van Onzen |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands |
| authorships[9].author.id | https://openalex.org/A5103402244 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Peter J. Hudson |
| authorships[9].affiliations[0].raw_affiliation_string | Avipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Peter J. Hudson |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Avipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia |
| authorships[10].author.id | https://openalex.org/A5017460653 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-3690-2087 |
| authorships[10].author.display_name | Marc S. Robillard |
| authorships[10].countries | NL |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210128216 |
| authorships[10].affiliations[0].raw_affiliation_string | Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands |
| authorships[10].institutions[0].id | https://openalex.org/I4210128216 |
| authorships[10].institutions[0].ror | https://ror.org/0364yac91 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210128216 |
| authorships[10].institutions[0].country_code | NL |
| authorships[10].institutions[0].display_name | Tagworks Pharmaceuticals (Netherlands) |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Marc S. Robillard |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Tagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41467-019-08376-x.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10756 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.5849000215530396 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Estrogen and related hormone effects |
| related_works | https://openalex.org/W2143004018, https://openalex.org/W2330362314, https://openalex.org/W2435669318, https://openalex.org/W1995639836, https://openalex.org/W2893386726, https://openalex.org/W4362530235, https://openalex.org/W4214766446, https://openalex.org/W4362624859, https://openalex.org/W3092771134, https://openalex.org/W4313278730 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2020 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 8 |
| best_oa_location.id | doi:10.1038/s41467-019-08376-x |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S64187185 |
| best_oa_location.source.issn | 2041-1723 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2041-1723 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Nature Communications |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41467-019-08376-x.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nature Communications |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41467-019-08376-x |
| primary_location.id | doi:10.1038/s41467-019-08376-x |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S64187185 |
| primary_location.source.issn | 2041-1723 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2041-1723 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Nature Communications |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s41467-019-08376-x.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nature Communications |
| primary_location.landing_page_url | https://doi.org/10.1038/s41467-019-08376-x |
| publication_date | 2019-01-16 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.59435971 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |